Skip to main content

Critical Care Nursing

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
Speech-to-speech Voice-Cloning CareN/A1 trial
Active Trials
NCT06743321Not Yet Recruiting234Est. Dec 2027

Trial Timeline

Clinical trial activity over time

2026
2027
UNION therapeuticsSpeech-to-speech Voice-Cloning Care

Clinical Trials (1)

Total enrollment: 234 patients across 1 trials

NCT06743321UNION therapeuticsSpeech-to-speech Voice-Cloning Care

Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients

Start: Aug 2026Est. completion: Dec 2027234 patients
N/ANot Yet Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.